Resumen
Early-career academic cardiologists, who many believe are an important component of the future of cardiovascular care, face myriad challenges. The Early Career Section Academic Working Group of the American College of Cardiology, with senior leadership support, assessed the progress of this cohort from 2013 to 2016 with a global perspective. Data consisted of accessing National Heart, Lung, and Blood Institute public information, data from the American Heart Association and international organizations, and a membership-wide survey. Although the National Heart, Lung, and Blood Institute increased funding of career development grants, only a small number of early-career American College of Cardiology members have benefited as funding of the entire cohort has decreased. Personal motivation, institutional support, and collaborators continued to be positive influential factors. Surprisingly, mentoring ceased to correlate positively with obtaining external grants. The totality of findings suggests that the status of early-career academic cardiologists remains challenging; therefore, the authors recommend a set of attainable solutions.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 2290-2303 |
| Número de páginas | 14 |
| Publicación | Journal of the American College of Cardiology |
| Volumen | 70 |
| N.º | 18 |
| DOI | |
| Estado | Published - oct 31 2017 |
Nota bibliográfica
Publisher Copyright:© 2017 American College of Cardiology Foundation
Financiación
Develop funding mechanisms outside of federal grants that can fund protected research time at >75% effort during the fellowship yrs for >2 yrs. Dr. Tong is supported by US National Institutes of Health (NIH) grants K08HL114877 and R03HL140266. Dr. Madhur is supported by US NIH grants K08HL121671 and DP2HL137166. Dr. Hill is supported by US NIH grants R01HL120732, R01HL126012, R01HL128215, and T32HL125247. Dr. Mann is supported by US NIH grants R01HL111094, T32HL007081, and U10HL110309. Dr. Raj is supported by the Canadian Institutes of Health Research (grant MOP142426) and the Cardiac Arrhythmia Network of Canada (grant SRG-17-P27). Dr. Mann is a consultant for Novartis (PARADISE trial). Dr. Hira has received honoraria from Abiomed and Abbott Vascular. Dr. Raj provides industry consulting for GE Healthcare and Lundbeck and research enrollment for Medtronic. Dr. Freeman has received non-promotional speaking fees from Boehringer Ingelheim. Dr. Gopinathannair has received speaking honoraria from Pfizer, Bristol-Myers Squibb, Zoll Medical, Abbott Medical, and HealthTrust PG. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
| Financiadores | Número del financiador |
|---|---|
| Cardiac Arrhythmia Network of Canada | SRG-17-P27 |
| National Institutes of Health (NIH) | |
| National Heart, Lung, and Blood Institute (NHLBI) | R01HL128215, DP2HL137166, U10HL110309, R01HL111094, K08HL121671, R01HL126012, T32HL125247, T32HL007081, R03HL140266, R01HL120732, K08HL114877 |
| Canadian Institutes of Health Research | MOP142426 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine